{
  "paper_metadata": {
    "pmid": "34290354",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for BRCA2, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6193C>T",
      "protein_notation": "p.Gln2065Ter",
      "genomic_position": null,
      "clinical_significance": "novel",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Not reported in detail.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "low",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is noted as novel and has not been reported previously.",
      "key_quotes": [
        "To our knowledge, two mutations in BRCA2 (c.6193C>T in exon 11 and c.1013del in exon 10) have not been reported previously in any database."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1013del",
      "protein_notation": "p.Ala338Metfs",
      "genomic_position": null,
      "clinical_significance": "novel",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Not reported in detail.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "low",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is noted as novel and has not been reported previously.",
      "key_quotes": [
        "To our knowledge, two mutations in BRCA2 (c.6193C>T in exon 11 and c.1013del in exon 10) have not been reported previously in any database."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.2254_2257del",
      "protein_notation": "p.Asp752Phefs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 11,
        "demographics": "not specified",
        "phenotype": "not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Not reported in detail.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Detected in multiple patients.",
      "key_quotes": [
        "Nineteen (25.3%) of the mutations detected in our patients were either (c.2254_2257del) or (exon 5\u201311 duplication); both in BRCA2 gene and were detected in 11 and 8 different patients, respectively."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "exon 5\u201311 duplication",
      "protein_notation": "Absent or disrupted protein product",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 8,
        "demographics": "not specified",
        "phenotype": "not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Not reported in detail.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Detected in multiple patients.",
      "key_quotes": [
        "Nineteen (25.3%) of the mutations detected in our patients were either (c.2254_2257del) or (exon 5\u201311 duplication); both in BRCA2 gene and were detected in 11 and 8 different patients, respectively."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "Rates of positive BRCA1 and BRCA2 mutations; subgroup analysis.",
      "variants_extracted": 4
    },
    {
      "table_name": "Table 4",
      "table_caption": "Types of BRCA2 mutations.",
      "variants_extracted": 4
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 4,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted successfully."
  }
}